DPP4 and diabetes mellitus: There was no significant difference in patients’ characteristics between study groups, and we recruited only the patients with diabetes who have HbA1c levels at ≤7.5% to evaluate the effects of DPP-4 inhibitors on study parameters, independent of the blood glucose-lowering effect.